ESS Tech outlined its strategic pivot toward sodium-ion battery technology during a presentation at the Micro-Cap Virtual Conference hosted by Sidoti & Company on August 19, 2026. The company, which went public via a 2021 SPAC transaction raising over $200 million, has reoriented its focus after spending four years developing iron flow batteries under founder-led leadership from 2011 to 2021.
The shift follows a review initiated in late 2024, culminating in the appointment of Drew Buckley as CEO in January 2026. Buckley emphasized the commercial limitations of the iron flow platform, noting that ESS had effectively attempted to "build the airplane as they were flying it," depleting capital without achieving scalable deployment. The company now pursues a dual-platform strategy, retaining iron flow for long-duration storage while advancing sodium-ion technology for shorter-duration, higher-power applications.
Sodium-ion batteries are positioned to address two key market dynamics: cost competitiveness amid U.S. import tariffs on lithium-ion batteries from China and operational advantages for high-power demand scenarios such as AI data centers. Buckley highlighted that a Chinese lithium-ion battery priced at $1.00 would rise to $1.40 after a 40% tariff, whereas a U.S.-produced sodium-ion battery could cost $1.10 to $1.20 at small scale. With a domestic tax credit of 40% to 50%, the net cost could fall to $0.70 to $0.80, creating a pricing edge.
The company has secured partnerships, including a collaboration with Alsym announced in Q2 2026, and a letter of intent with Juniper Energy for a major utility delivery in California by late 2027. ESS projects sodium-ion production capacity in the range of 200 gigawatt-hours to 500 gigawatt-hours annually, targeting customer interest exceeding $1 billion. A sodium-ion prototype demonstration is planned for the end of 2026, with revenue expected to ramp in 2027.
ESS Tech’s stock, trading at $0.69 with a market capitalization of $22.52 million, has declined 64% year-to-date and 57% over the past year from a 52-week high of $13.87, though it gained 20% in the prior week. The company’s current ratio stands at 0.68, and its financial health score is rated as "WEAK" at 1.24 out of 5 by InvestingPro.
